Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
The Journal of Investigative Dermatology
|
November 6, 1998
Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation
Y Herouy, A E May, G Pornschlegel, et al.
The Journal of Biological Chemistry
|
October 25, 1990
Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin
K T Preissner, J Grulich-Henn, H J Ehrlich, et al.
Investigative Ophthalmology & Visual Science
|
December 10, 1999
Vitronectin gene expression in the adult human retina
D H Anderson, G S Hageman, R F Mullins, et al.
Journal of Neuroimmunology
|
April 3, 2009
Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome
V Fühlhuber, S Bick, A Kirsten, et al.
Thrombosis and Haemostasis
|
December 2, 1991
In vitro studies of antiphospholipid antibodies and its cofactor, beta 2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation
J D Oosting, R H Derksen, T M Hackeng, et al.
The Journal of Biological Chemistry
|
October 25, 1988
Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin)
P J Declerck, M De Mol, M C Alessi, et al.
Blood
|
July 11, 2000
Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions
T Chavakis, S M Kanse, F Lupu, et al.
FEBS Letters
|
July 5, 1993
Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor
W März, A Beckmann, H Scharnagl, et al.
Thrombosis and Haemostasis
|
March 1, 1995
Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo
L Liu, L Dewar, Y Song, et al.
Experimental Cell Research
|
May 1, 1997
Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
L Kjøller, S M Kanse, T Kirkegaard, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
The Journal of Investigative Dermatology
|
November 6, 1998
Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation
Y Herouy, A E May, G Pornschlegel, et al.
The Journal of Biological Chemistry
|
October 25, 1990
Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin
K T Preissner, J Grulich-Henn, H J Ehrlich, et al.
Investigative Ophthalmology & Visual Science
|
December 10, 1999
Vitronectin gene expression in the adult human retina
D H Anderson, G S Hageman, R F Mullins, et al.
Journal of Neuroimmunology
|
April 3, 2009
Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome
V Fühlhuber, S Bick, A Kirsten, et al.
Thrombosis and Haemostasis
|
December 2, 1991
In vitro studies of antiphospholipid antibodies and its cofactor, beta 2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation
J D Oosting, R H Derksen, T M Hackeng, et al.
The Journal of Biological Chemistry
|
October 25, 1988
Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin)
P J Declerck, M De Mol, M C Alessi, et al.
Blood
|
July 11, 2000
Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions
T Chavakis, S M Kanse, F Lupu, et al.
FEBS Letters
|
July 5, 1993
Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor
W März, A Beckmann, H Scharnagl, et al.
Thrombosis and Haemostasis
|
March 1, 1995
Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo
L Liu, L Dewar, Y Song, et al.
Experimental Cell Research
|
May 1, 1997
Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
L Kjøller, S M Kanse, T Kirkegaard, et al.
Page
of 15